reported suffering from headache progression and visual disturbances. Fundus examination showed worsening of the papilledema (Frisén stage III), and visual acuity was 6/9 bilaterally. The patient was hospitalized for the second time, and a second LP revealed an opening pressure of 27 cm H 2 O. Thirty milliliters of CSF was drained, and medications were gradually increased to 250 mg of acetazolamide five times a day and 50 mg of topiramate twice a day. Nevertheless, no recovery was achieved in the following 10-day hospitalization period. Instead, her symptoms progressed, and her visual acuity deteriorated to the level of 4/5 bilaterally. Fundus examination at that time revealed newly emerging papillary hemorrhages. During that interval, LP treatment was administered two more times with opening pressures of 28 and 35 mm H 2 O, respectively, which failed to help the patient's clinical status. Given the malignant clinical course of the patient, neurosurgery was consulted urgently, and lumboperitoneal shunt surgery was decided on. Following shunt surgery, a slight recovery was achieved in the acute period. Therefore, to be sure that the shunt was working, LP was repeated in the 1st week after the shunt surgery, which showed normalization of the CSF pressure (opening pressure 16 mm H 2 O). For the second time, the patient was discharged on intensive medical therapy (250 mg of acetazolamide five times a day, 50 mg of topiramate twice a day). In the subacute period, a moderate recovery was achieved.
Eight months later, the patient was admitted with worsening headaches and visual disturbances over the last month. Given the progression of her papilledema, she was hospitalized and LP was performed, which showed an opening pressure of 24 mm H 2 O, proving malfunction of the lumboperitoneal shunt (Fig. 1) .
When the patient was further evaluated, OSAS was suspected. Thus, otolaryngology was consulted. Otolaryngological examination revealed significantly hyponasal speech, a history of severe witnessed apneas, and prominent morning symptoms, such as sleeplessness and irritability, together with severe headaches. The patient also complained about dyspnea and unbearable worsening of sleep quality during upper respiratory tract infections. Physical examination showed grade 4 tonsillar hypertrophy (occupying more than 75% of the airway), class 2 oropharynx, and grade 2 hypopharynx. Taken together, these findings indicated tonsillectomy due to obstructive tonsillar hypertrophy. Preoperative polysomnography was not needed. The Epworth Sleepiness Scale (ESS) score was calculated as 17. As a result of interdepartmental consultations and recent literature data pointing to an association between OSAS and IIH in terms of a causal relationship, 18 surgery was predicted to improve IIH symptoms as well as the OSAS symptoms, and shunt revision surgery was not considered in the acute period.
Operation and Postoperative Course
Tonsillectomy was performed successfully. Soon after the operation, significant amelioration of the OSAS symptoms was attained. Moreover, a dramatic recovery in IIH symptoms also occurred. Soon after surgery, she fully recovered from the headaches and visual symptoms, and fundus examinations revealed the normalization of papilledema. Optical coherence tomography (OCT) also confirmed the gradual improvement of papilledema in comparison to its preoperative status, and perimetry showed total recovery of preoperative bilateral visual field defects (Figs. 2 and 3). By the last visit 3 months after surgery, the headaches had stopped and the papilledema had regressed to the level of bilateral stage I despite significant decrements in the medications (only 250 mg of acetazolamide twice a day was continued). However, polysomnography, also performed at the 3rd postoperative month, revealed persistent OSAS but at a mild degree (Apnea Hypopnea Index: 14.6/hr). Remarkably, a concurrent ESS score was 0.
Discussion
Idiopathic intracranial hypertension is identified as benign intracranial hypertension because of its usual course of spontaneous resolution, leaving few sequelae. 10 Our patient had developed progressive visual loss and worsening papilledema, which did not respond to LPs and high-dosage medications, thus confirming a diagnosis of malignant IIH. Although there is no prospective controlled study comparing conservative and surgical treatments, progressive visual loss not responding to repeated LPs and medical therapy is usually treated with surgery. 2 In our case, prompt lumboperitoneal shunt insertion provided moderate improvement in resistant symptoms and gradual improvement in the papilledema. Eight months later, however, symptoms recurred and a newly performed LP showed increased CSF pressure (24 mm H 2 O), confirming malfunction of the lumboperitoneal shunt. At that time, tonsillectomy was performed, which provided excellent improvement in the patient's symptoms (namely headache and visual complaints) as well as abnormal visual findings. In our opinion, this report of recovery from IIH via OSAS surgery may provide crucial insight into the mechanisms underlying IIH.
Obstructive sleep apnea syndrome can be described as a disorder characterized by repetitive episodes of hypopnea or apnea due to the collapse of the upper respiratory tract during sleep despite ongoing breathing effort. 3 Polysomnography is a recommended tool for evaluating OSAS; however, there is no gold standard for the diagnosis. The association of OSAS and cerebral vasodilatation-linked intracranial pressure (ICP) increments is a recognized entity among specialists. 8, 15 Remarkable studies of ICP monitoring during sleep in patients with OSAS have shown normal ICP values during the awake period but a slow increase and then a steep increase in ICP during sleep. Given the findings in these studies, their authors have suggested that the slow increase may be associated with hypercapnia and hypoxia, whereas the steep increase at the end of apneic episodes has been related to an increase in intraarterial pressure and central venous pressure. 8 On the other hand, central obesity has also been hypothesized to be an important factor for the development of IIH in OSAS, causing increased abdominal pressure, which leads to poor venous drainage from the brain, resulting in increased ICP. 4 In a distinct report by Wardly et al., a view of upper airway structure compression in central obesity and its effect as a contributor to OSAS mechanisms has been discussed in the setting of IIH pathophysiology. 17 In addition, Wardly has hypothesized a possible effect of obesity leading to a propensity for jugular venous collapsibility or narrowing, contributing to increased ICP via increased resistance in the jugular veins. 18 Despite these hypotheses, however, there is still no consensus on an association between these two entities. For example, in a crucial polysomnography study conducted on 24 newly diagnosed IIH patients, OSAS was not found to be an independent factor in the severity and prevalence of IIH. 16 In accordance, papilledema was also not found in anyone in a large cohort of OSAS patients, leading to a reinvestigation of the influence of OSAS in increased ICP as well as its impact on IIH pathophysiology. 14 Altogether, although the association between IIH and OSAS is a recognized issue of discussion, underlying mechanisms as well as a possible causality between these disorders have not been elucidated as yet. Hence, we think that our report may provide crucial insight into the impact of OSAS in IIH pathophysiology. Dramatic and rapid improvement (in both clinical and laboratory findings) after OSAS surgery was documented in our patient, strongly supporting the influence of OSAS as an etiological agent in IIH. For the treatment of OSAS, continuous positive airway pressure (CPAP) is recommended as first-line therapy, and surgical options should be considered when noninvasive medical therapy fails. 3 In OSAS, various types of surgical modalities are indicated to modify the various sites of airway obstruction, including nasal surgery, surgeries of the oropharynx (tonsillectomy, etc.), and craniofacial surgery. 5 In our patient, however, the obstructive tonsillar hypertrophy was prominent and thus we decided on tonsillectomy as the first-line therapy for OSAS.
In a previous report, gradual improvement of papilledema via CPAP treatment in a patient with OSAS was also documented. 7 In another unique report, a child who presented with IIH also had a complete and immediate cure via OSAS surgery. 9 In an adult patient with IIH and accompanying OSAS, Wardly et al. found that counterclockwise maxillomandibular advancement (CC-MMA), a surgical modality for OSAS, provided recovery from IIH. 17 Nevertheless, these authors drew attention to the persistence of OSAS and formed their hypothesis on the basis of a mechanism that could be solely associated with specific features of CC-MMA, rather than OSAS pathophysiology. Hence, they suggested that the positive outcome was effected via mandibular advancement producing a decrease in jugular venous resistance, allowing improved absorption of CSF. In this patient, however, and as discussed by the authors, there may be some crucial questions regarding the actual existence of IIH, as papilledema was absent and a prominent increase in ICP had not occurred. Although residual findings of OSAS symptoms persisted in the follow-up of the patient, a significant recovery was achieved, which seems to be underestimated in the report. Hence, we think that the rationale for focusing on a mechanism of jugular venous resistance decrease, rather than on recovering from OSAS pathophysiology (which is a much more supported theory), may also be questionable. To our knowledge, ours is the first report of an adult IIH patient successfully treated with tonsillectomy by aiming to re- lieve OSAS. The rapid recovery was also demonstrated via serial OCT tests, a useful quantitative tool for the determination and follow-up of papilledema throughout its whole clinical course. 1, 13 Through the illustration of our extremely rare case and the related literature review, we have clearly shown OSAS as an independent etiological factor in IIH, which should be considered, particularly in patients with malignant IIH. An interesting point in our patient was the prominent finding of papilledema, which did not have an overwhelming response to shunt surgery (even in the immediate postoperative period). The absence of a response may be explained by mechanisms other than ICP and by the OSAS itself. For instance, OSAS-related increased oxidative stress and inflammation, which lead to neuronal damage and apoptosis, have been hypothesized to be associated with optic nerve pathology. 7 Of note, papilledema has also been frequently reported in OSAS patients who did not meet the criteria for IIH. 7, 11 Future studies with a larger number of patients with both IIH and OSAS are warranted to clarify these arguments. Such studies may provide important perspectives regarding the pathophysiology of IIH (especially some specific IIH subtypes) as well as treatment-based clinical approaches to some subgroups of IIH.
Key Messages
• Obstructive sleep apnea should be kept in mind as an independent etiological factor in IIH, particularly in patients with malignant IIH.
• A patient-specific multimodal approach is needed in these IIH patients for the best clinical responses.
• Distinct mechanisms other than ICP increments may be responsible for prominent papilledema presentations in IIH, which constitutes a crucial issue for clarification in future studies.
